期刊档案
European Medical Journal
ISSN 2397-6764 · European Medical Journal · United Kingdom
European Medical Journal 钻石开放获取(无 APC),免版面费,投稿社区反馈审稿约 33 周,2025 年发文 57 篇。
研究范围
研究范围与定位
European Medical Journal 由 European Medical Journal 出版。按 OpenAlex 近年发文统计,该刊主要发表 Asthma and respiratory diseases、Dermatology and Skin Diseases、Chronic Obstructive Pulmonary Disease (COPD) Research 等主题的论文,这 3 个主题约占 20.9%。(根据 OpenAlex 主题统计与中科院分区数据生成)
The EMJ is an online only, peer reviewed, open access general journal, targeted towards readers in the medical sciences. We aim to make all our articles accessible to readers from any medical discipline EMJ allows healthcare professionals to stay abreast of key advances and opinions across Europe EMJ aims to support healthcare professionals in continuously developing their knowledge, effectiveness, and productivity. The editorial policy is designed to encourage discussion among this peer group EMJ is published quarterly and comprises of review articles, case reports, practice guides, theoretical discussions, and original research EMJ also publishes 18 therapeutic area journals, which provide concise coverage of salient developments at the leading European congresses. These are published annually, approximately 6 weeks after the relevant congress. Further details can be found on our website: www.emjreviews.com
摘自期刊官网 Aims & Scope
主要研究主题 OpenAlex 近年发文统计,占比为近似值
- Asthma and respiratory diseasesMedicine7.3%
- Dermatology and Skin DiseasesMedicine7.1%
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine6.5%
- COVID-19 Clinical Research StudiesMedicine4.9%
- Spondyloarthritis Studies and TreatmentsMedicine4.9%
- Urinary Bladder and Prostate ResearchMedicine4.6%
- Psoriasis: Treatment and PathogenesisImmunology and Microbiology4.6%
- Genomics and Rare DiseasesBiochemistry, Genetics and Molecular Biology4.6%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表( 2025年3月升级版)未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》( 2026年3月发布)未收录
该期刊未被此版本分区表收录。
期刊分区表( 2023年12月旧的升级版)未收录
该期刊未被此版本分区表收录。
数据库收录
DOAJLetPub
国际期刊预警名单:各版本均未列入LetPub
期刊官网自述收录
Google Scholar出版商官网
期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- h-index
- 16OpenAlex ·
- i10-index
- 40OpenAlex ·
- 两年平均被引
- 0.58OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
逐年发文量 OpenAlex 统计 · 累计 574 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 56 | 56 | 141 |
| 2025 | 57 | 57 | 224 |
| 2024 | 70 | 70 | 192 |
| 2023 | 53 | 53 | 157 |
| 2022 | 51 | 51 | 210 |
| 2021 | 37 | 37 | 190 |
不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
- 平均审稿速度(社区反馈)
- 33 WeeksLetPub ·
- 投稿到发表(期刊自报)
- 约 33 周DOAJ ·
- 评审方式
- 双盲同行评审DOAJ
社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
所有文章开放获取,且不向作者收取文章处理费。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | 无文章处理费 | 无 | CC BY-NC | |
| LetPub | 无文章处理费 | 无 | — | |
| 出版商官网 | 无文章处理费 | — | — |
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。
投稿要求
文章类型与投稿政策(官网)
投稿准备要点4 项,摘自作者指南
- 关键词
- 3–10 个
- 推荐审稿人
- 可选
- Highlights(研究亮点)
- 必须提供
- 投稿信(Cover letter)
- 必须提供
接收的文章类型10 种
- case reportOriginal research (abstract: structured, ≤250 words; main text: <3,000 words +/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%). Ori…未说明篇幅
- editorialThe Editorial Staff will evaluate disclosed conflicts to determine if they are significant enough to preclude publication or require additional scrutiny. Review…未说明篇幅
- literature reviewOriginal research (abstract: structured, ≤250 words; main text: <3,000 words +/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%). Ori…未说明篇幅
- meta-analysisOriginal research (abstract: structured, ≤250 words; main text: <3,000 words +/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%). Ori…未说明篇幅
- narrative reviewOriginal research (abstract: structured, ≤250 words; main text: <3,000 words +/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%). Ori…未说明篇幅
- original researchOriginal research (abstract: structured, ≤250 words; main text: <3,000 words +/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%). Ori…未说明篇幅
- perspectiveOriginal research (abstract: structured, ≤250 words; main text: <3,000 words +/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%). Ori…未说明篇幅
- reviewOriginal research (abstract: structured, ≤250 words; main text: <3,000 words +/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%). Ori…未说明篇幅
- review articleOriginal research (abstract: structured, ≤250 words; main text: <3,000 words +/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%). Ori…未说明篇幅
- systematic reviewOriginal research (abstract: structured, ≤250 words; main text: <3,000 words +/-10%; combined maximum of 3 tables or figures; maximum 60 references +/-10%). Ori…未说明篇幅
官网政策摘录作者资格、利益冲突、出版伦理、许可与版权、开放获取、同行评审、查重、预印本
- 作者资格 Authorship
作者身份意味着对已发表工作的责任和问责,并为研究人员对研究的贡献提供署名。作者身份的分配对象是对研究的分析和解释做出贡献但可能未参与研究构思和设计的个人。每位作者的贡献和责任都应包括在内。作者可能希望致谢其他贡献者,例如在过程中提供帮助但未达到被列为作者所需贡献的教授。 模型中文摘要
Authorship implies responsibility and accountability for published work as well as providing credit for a researcher’s contributions to a study. Assignment of authorship is to individuals who have contributed to the analysis and interpretation of a study but who may not have contributed to its conception and design. The contribution and responsibility of every author should be included. Authors ma…
原文 ↗出版商官网 ·- 利益冲突 Disclosure and Conflicts of Interest
当对稿件的专业判断可能受到次要利益(例如经济利益)的影响时,即存在利益冲突。例如,这包括披露作者(或其近亲)受雇、签约、提供服务或以其他方式合作的任何制药、生物制剂、医疗器械和诊断公司的名称(及关系)。 模型中文摘要
A conflict of interest can be said to exist when professional judgement concerning the manuscript may be influenced by a secondary interest (e.g., financial gain). For example, this would include disclosing the names of (and relationship with) any pharmaceutical, biologics, medical device, and diagnostic companies for which an author (or one of their close family members) is employed, contracted f…
原文 ↗出版商官网 ·- 出版伦理 Ethical Approval
我们期望所有从事医学研究的作者遵循《赫尔辛基宣言》。研究文章:作者应能够根据要求提交其机构审查委员会或伦理委员会表明批准该研究的声明。作者还应尽一切努力保护患者隐私和匿名性;只有在至关重要且不可避免的情况下才应包含可能识别身份的信息。 模型中文摘要
We expect that all authors conducting medical research follow the Declaration of Helsinki, which can be viewed here: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/. Research articles: Authors should be able to submit, upon request, a statement from their institutional review board or ethics committee indicating approv…
原文 ↗出版商官网 ·- 许可与版权 Copyright
Copyright is the legal right given to the creator of a piece of work. The types of work to which copyright applies include literary, dramatic, musical, artistic, sound recording, films, broadcasts and cable programmes, and typographical arrangement of published editions. Usually for authors copyrighted material will be figures, tables or photos. If you want to include an image in your manuscript t…
原文 ↗出版商官网 ·- 开放获取 Open Access
We are an open-access journal in accordance with the Creative Commons Attribution-Non Commercial 4.0 (CC BY-NC 4.0)< license. This permits users to: Share – Copy and redistribute the material in any medium or format. Adapt – Remix, transform, and build upon the material. Under the following terms: Attribution – You must give appropriate credit, provide a link to the license, and indicate if change…
原文 ↗出版商官网 ·- 同行评审 Peer Review Process
所有提交的稿件最初均由编辑团队进行审查。在此阶段,如果我们认为稿件质量不够高、不符合我们的指南或不在期刊范围内,则可能会在同行评审之前被拒稿。通过初步审查过程的稿件将被送至至少两名独立审稿人进行同行评审。该过程为双盲。论文将根据同行评审反馈、作者在修改方面的配合程度以及编辑的最终选择而被选中发表。 模型中文摘要
All submissions are initially reviewed by the Editorial team. At this stage, papers may be rejected before peer review if we feel that they are not of high enough quality, do not follow our guidelines, or are not within the scope of the journal. This ensures that authors are given a quick decision if their paper is unsuitable. Papers that pass the initial review process will be sent out for peer r…
原文 ↗出版商官网 ·- 查重 Policy on Plagiarism
通过向EMJ提交稿件,即表示理解该稿件为原创稿件、未发表且未在其他地方考虑。伪造或捏造数据、抄袭(包括未经适当引用而重复发表作者自己的作品)以及盗用他人作品均是不可接受的做法。通过Kriyadocs提交平台提交给EMJ的所有稿件都将进行抄袭筛查。任何这方面的学术不端行为都将受到严肃对待,并根据COPE指南进行处理。 模型中文摘要
By submitting your manuscript to the EMJ it is understood that it is an original manuscript, is unpublished work and is not under consideration elsewhere. Falsification or fabrication of data, plagiarism, including duplicate publication of the authors’ own work without proper citation, and misappropriation of the work are all unacceptable practices. All manuscripts submitted to EMJ via the Kriyado…
原文 ↗出版商官网 ·- 预印本 Preprints
EMJ考虑接受以前作为预印本发表的文章的提交。如果您的提交稿件已发布在预印本服务器上,请告知我们的编辑人员,并提供预印本的链接。在稿件被接受发表后,我们期望作者确保预印本被修改以引导读者阅读其文章的最终发表版本。 模型中文摘要
EMJ considers submissions of articles previously published as preprints. Please inform our Editorial staff if your submitted manuscript has been posted on a preprint server and please provide a link to the preprint. Subject to acceptance of the manuscript for publication, we expect the authors to ensure that preprints are amended to point readers to the final published version of their article.
原文 ↗出版商官网 ·
摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。
基本信息
出版信息与官方入口
- 出版商
- European Medical Journal
- 出版国家或地区
- United Kingdom
- 出版语言
- English
- ISSN
- 2397-6764
- 官方链接
- 期刊主页 ↗LetPub
- 作者指南 ↗LetPub
- Aims & Scope ↗LetPub
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗LetPub
- 编委会 ↗LetPub
常见问题
关于 European Medical Journal 的常见问题
European Medical Journal 的审稿周期多长?
投稿社区反馈的平均审稿速度为约 33 周。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。
European Medical Journal 的投稿格式要求是什么?
据期刊作者指南:关键词:3–10 个;推荐审稿人:可选;Highlights:必须提供;投稿信:必须提供。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。
European Medical Journal 被哪些数据库收录?
据 LetPub 与 DOAJ 记录,European Medical Journal 被 DOAJ 收录。
European Medical Journal 是开放获取期刊吗?版面费多少?
European Medical Journal 为钻石开放获取(无 APC)。不收取文章处理费。
来源与更新
本页事实来自 LetPub、OpenAlex、DOAJ、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-25 归档)。最近更新:。